Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
about
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patientsToxicity after prolonged (more than four weeks) administration of intravenous colistinColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyColistin in the 21st century.Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosingClinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.Polymyxins revisited.Treatment options for multidrug-resistant nonfermenters.Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid ATreatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.Pharmacokinetics of intravenous polymyxin B in critically ill patients.Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection.
P2860
Q24651466-AC0E09A2-D88A-4F05-BEA3-45C12BC33C9AQ24798835-069B9CD3-3571-4BF4-B474-4D79D1A32F86Q27014993-2063FDF7-6683-4DCE-B660-112D3A6C9EA0Q33847509-D372A1DA-33B2-45BD-80C9-A5D6AB5176D1Q33938143-8E755587-8316-48D9-8C70-27A1734E191AQ35541277-50286EE5-469A-4500-9BE3-6078B972480DQ37029217-4EC36543-81E3-4A02-9EC3-8036FA727B4FQ37215935-4BA19956-1B39-4824-9922-06A2F881939BQ37700555-387C08C6-140A-42AE-9EFA-DFBED576FA2EQ38040733-6A2CEE09-8647-45B5-8F70-E235053C6634Q38186636-369F289E-DAF6-49FA-8E1E-233018D3155BQ40387809-8482DF70-9F86-4DAF-A152-39F5A0BD57B8Q44417867-CB5944D9-138A-4931-A628-F84AB8C53A29Q44808038-48DDF92C-6DAF-4705-8A97-CFEEF8936C90Q46153446-CF8A2C37-7582-4F02-B4EE-DB4AAD2A6A54
P2860
Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@ast
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@en
type
label
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@ast
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@en
prefLabel
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@ast
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@en
P2093
P2860
P356
P1476
Safety and tolerability of bol ...... n adults with cystic fibrosis.
@en
P2093
C Etherington
J J Strong
M H Goldman
S P Conway
P2860
P304
P356
10.1345/APH.19370
P407
P577
2000-11-01T00:00:00Z